136 related articles for article (PubMed ID: 38837464)
41. Serum metabolomic profiling reveals important difference between infants with and without subsequent recurrent wheezing in later childhood after RSV bronchiolitis.
Zhang X; Peng D; Zhang X; Wang X; Chen N; Zhao S; He Q
APMIS; 2021 Mar; 129(3):128-137. PubMed ID: 33155332
[TBL] [Abstract][Full Text] [Related]
42. Comparison of clinical features of acute lower respiratory tract infections in infants with RSV/HRV infection, and incidences of subsequent wheezing or asthma in childhood.
Ding Q; Xu L; Zhu Y; Xu B; Chen X; Duan Y; Xie Z; Shen K
BMC Infect Dis; 2020 May; 20(1):387. PubMed ID: 32473625
[TBL] [Abstract][Full Text] [Related]
43. Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012.
Reeves RM; Hardelid P; Gilbert R; Warburton F; Ellis J; Pebody RG
Influenza Other Respir Viruses; 2017 Mar; 11(2):122-129. PubMed ID: 28058797
[TBL] [Abstract][Full Text] [Related]
44. Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus.
van Woensel JB; Kimpen JL; Sprikkelman AB; Ouwehand A; van Aalderen WM
Pediatr Pulmonol; 2000 Aug; 30(2):92-6. PubMed ID: 10922130
[TBL] [Abstract][Full Text] [Related]
45. [The correlation factor about respiratory syncytial virus bronchiolitis and post-bronchiolitis wheezing in infant].
Tian M; Zhao DY; Wen GY; Shi SY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):371-4. PubMed ID: 20387490
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the Western Region of The Gambia.
Weber MW; Milligan P; Hilton S; Lahai G; Whittle H; Mulholland EK; Greenwood BM
Int J Epidemiol; 1999 Feb; 28(1):157-62. PubMed ID: 10195682
[TBL] [Abstract][Full Text] [Related]
47. Serum bilirubin is associated with a reduced risk of subsequent recurrent wheezing following acute respiratory syncytial virus bronchiolitis.
Zhang X; Zhang X; Xu H; Tang X; Zhao S; Yang H
Pediatr Pulmonol; 2023 Aug; 58(8):2333-2339. PubMed ID: 37222307
[TBL] [Abstract][Full Text] [Related]
48. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe.
Mao Z; Li X; Dacosta-Urbieta A; Billard MN; Wildenbeest J; Korsten K; Martinón-Torres F; Heikkinen T; Cunningham S; Snape MD; Robinson H; Pollard AJ; Postma M; Dervaux B; Hens N; Bont L; Bilcke J; Beutels P;
Vaccine; 2023 Apr; 41(16):2707-2715. PubMed ID: 36941154
[TBL] [Abstract][Full Text] [Related]
49. Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis.
Brunwasser SM; Snyder BM; Driscoll AJ; Fell DB; Savitz DA; Feikin DR; Skidmore B; Bhat N; Bont LJ; Dupont WD; Wu P; Gebretsadik T; Holt PG; Zar HJ; Ortiz JR; Hartert TV
Lancet Respir Med; 2020 Aug; 8(8):795-806. PubMed ID: 32763206
[TBL] [Abstract][Full Text] [Related]
50. U-EPX levels and wheezing in infants and young children with and without RSV bronchiolitis.
Kristjánsson S; Wennergren D; Eriksson B; Thórarinsdóttir H; Wennergren G
Respir Med; 2006 May; 100(5):878-83. PubMed ID: 16198099
[TBL] [Abstract][Full Text] [Related]
51. Longitudinal plasma cytokine concentrations and recurrent wheezing after RSV bronchiolitis.
Rodríguez-Fernández R; González-Martínez F; González-Sánchez MI; Hernández-Sampelayo T; Jimenez JL; Muñoz-Fernández MA; Garcia-Martos C; Mejias A; Ramilo O
Cytokine; 2021 Apr; 140():155434. PubMed ID: 33513527
[TBL] [Abstract][Full Text] [Related]
52. Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children.
Singleton RJ; Redding GJ; Lewis TC; Martinez P; Bulkow L; Morray B; Peters H; Gove J; Jones C; Stamey D; Talkington DF; DeMain J; Bernert JT; Butler JC
Pediatrics; 2003 Aug; 112(2):285-90. PubMed ID: 12897275
[TBL] [Abstract][Full Text] [Related]
53. Bronchiolitis, Regardless of Its Etiology and Severity, Is Associated With Increased Risk of Asthma: A Population-Based Study.
Muñoz-Quiles C; López-Lacort M; Díez-Domingo J; Orrico-Sánchez A
J Infect Dis; 2023 Oct; 228(7):840-850. PubMed ID: 37015894
[TBL] [Abstract][Full Text] [Related]
54. Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
Chirikov VV; Simões EAF; Kuznik A; Kwon Y; Botteman M
J Infect Dis; 2020 Mar; 221(8):1244-1255. PubMed ID: 30982895
[TBL] [Abstract][Full Text] [Related]
55. Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection.
McGinley JP; Lin GL; Öner D; Golubchik T; O'Connor D; Snape MD; Gruselle O; Langedijk AC; Wildenbeest J; Openshaw P; Nair H; Aerssens J; Bont L; Martinón-Torres F; Drysdale SB; Pollard AJ;
J Infect Dis; 2022 Aug; 226(Suppl 1):S45-S54. PubMed ID: 35902389
[TBL] [Abstract][Full Text] [Related]
56. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.
Garegnani L; Styrmisdóttir L; Roson Rodriguez P; Escobar Liquitay CM; Esteban I; Franco JV
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013757. PubMed ID: 34783356
[TBL] [Abstract][Full Text] [Related]
57. Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study.
Mochizuki H; Kusuda S; Okada K; Yoshihara S; Furuya H; Simões EAF;
Am J Respir Crit Care Med; 2017 Jul; 196(1):29-38. PubMed ID: 28152315
[TBL] [Abstract][Full Text] [Related]
58. Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?
Vittucci AC; Antilici L; Russo C; Musolino AMC; Cristaldi S; Cutrera R; Persia S; Di Maio CV; Raponi M; Perno CF; Villani A
Eur J Pediatr; 2023 Dec; 182(12):5303-5313. PubMed ID: 37728752
[TBL] [Abstract][Full Text] [Related]
59. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
[TBL] [Abstract][Full Text] [Related]
60. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study.
Martinón-Torres F; Carmo M; Platero L; Drago G; López-Belmonte JL; Bangert M; Díez-Domingo J; Garcés-Sánchez M
BMC Infect Dis; 2022 Sep; 22(1):759. PubMed ID: 36175846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
